While the participants got Dose 1 and Dose 2, they stayed overnight at
their study site for 4 days. The participants got Dose 1 of savolitinib on the first
day, just after their breakfast. They waited for 1 hour and 45 minutes, and then
they got Dose 2.
After the participants finished getting Dose 1 and Dose 2, they had to wait at least
14 days before getting Dose 3.
While the participants got Dose 3, they stayed overnight at their study site
for 8 days. The participants got Dose 3 on the first day, just after their breakfast.
After the participants got study treatment, they visited their study site 1
time. This visit happened about 2 to 3 weeks after the participants left their study
site after getting Dose 3. At this visit, the study doctors checked the health of the
participants.
What were the results of this study?
This is a summary of the main results from this study overall. The results each
participant had might be different and are not in this summary.
Researchers look at the results of many studies to decide which treatments work
best and are safest. Other studies may provide new information or different
results. Always talk to a doctor before making any treatment changes.
The websites listed at the end of this summary may have more information about
the study results.
5 | Clinical Study Results